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Abstract
The use of selective serotonin reuptake inhibitors (SSRIs) 
is rapidly growing among the general population. 
Researchers have identified only minimal empirical data 
regarding the SSRI-prescribing practices among primary 
care providers. The focus of this descriptive study was to 
explore SSRI-prescribing practices of primary care 
providers. Benner's (1984) Novice to Expert Model was the 
theoretical framework used to conduct this study. The 
research questions used to guide the research were as 
follows: What factors influence the prescribing practices
of primary care providers regarding SSRIs? And what are 
the perceived competency levels of primary care providers 
in prescribing SSRIs? The research design was a 
nonexperimental, descriptive design. A convenience sample 
of all primary care providers in a rural area was 
utilized. Data were obtained through a self-report survey 
using a researcher-developed demographic survey and the 
Dowell Prescribing Practice Questionnaire. Data were 
analyzed using descriptive statistics, and content 
analysis was used for any open-ended questions. The sample
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consisted of 30 primary care providers. The study found 
that the most prescribed antidepressants were SSRIs. 
Lexapro was the most often prescribed, while Luvox was the 
SSRI least often prescribed. Side effects were the most 
influential factor in choosing an SSRI. The majority of 
respondents do not recommend any other type of treatment 
before prescribing an antidepressant. Of the respondents 
who do prescribe another type of treatment, professional 
counseling and exercise were recommended most often. 
Overall, the majority of respondents felt very competent 
prescribing SSRIs as well as answering patients' questions 
related to SSRIs. Recommendations for further research 
included replication of the study with a larger, more 
diverse sample of primary care providers and conducting 
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Antidepressants are among the most commonly 
prescribed drugs in the world. Between 1990 and 1995, new 
or continued antidepressant prescriptions increased 
approximately 73%, and primary care office visits for 
depression doubled between 1988 and 1994 (Shell, 2001) .
The introduction of selective serotonin reuptake 
inhibitors (SSRIs) has brought about many changes in the 
treatment of depression and to the prescribing practices 
of health care providers. It is believed that the 
development of SSRIs in 1988 may have contributed to these 
patterns because of their favorable side effects and 
safety profiles (Stafford, MacDonald, & Finkelstein,
2001).
As the use of antidepressants, especially SSRIs, 
continues to grow in the primary care setting, more and 
more primary care providers will be involved in the 
treatment of depression. Minimal research has been 
identified regarding the SSRI-prescribing practices of 
primary care providers. The purpose of this study was to
2
examine the SSRI-prescribing practices among primary care 
providers in a southeastern state of the United States.
Establishment of the Problem
Selective serotonin reuptake inhibitors (SSRIs) is 
one of several categories of antidepressants. Since their 
introduction in the late 1980s, SSRIs have become one of 
the most widely prescribed classes of drugs (Weitzel & 
Jiwanlal, 2001). Although most antidepressants are equally 
effective in reversing depression in outpatients, SSRIs 
have become the initial drug of choice because they act at 
fewer neurotransmitter sites, produce fewer adverse side 
effects, and therefore are tolerated better by patients 
(Solnek & Seiter, 2002).
Lewis (2000) reported that nonpsychiatric providers 
see three fourths of patients treated in family practice 
clinics for depression. This increases the need for 
providers to be highly effective in the diagnosing and 
treating of depression.
Zwillich (1999) reported that the number of doctor 
office visits including an antidepressant prescription 
more than doubled between 1985 and 1994 to more than 24 
million. According to Zwillich (1999), researchers 
attribute the increase in prescriptions for 
antidepressants to the growing popularity of SSRIs.
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Ferguson (2001) reported the shift of depression 
management to primary care practitioners who manage heavy 
patient schedules across all therapeutic areas has created 
the need to enhance the successful treatment of depression 
by adapting new therapeutic strategies. The primary care 
provider must be competent in diagnosing depression and 
prescribing the treatment that will lead the client to 
optimal health. Ferguson (2000) reported that nearly 15% 
of patients who seek help for their depressive illness and 
are left untreated commit suicide within one month of 
being seen by a physician. Thus, early and accurate 
diagnosis of depressive disorders is an important part of 
the primary care provider's evaluation of every patient.
Ferguson (2001) also reported that the informed 
management of side effects by primary care practitioners 
supports successful treatment of depression. Primary care 
providers must be knowledgeable of the possible side 
effects and adverse reactions of SSRIs in order to safely 
prescribe them. The education of their clients regarding 
SSRIs also depends on the competence of the prescriber.
With the increased use of these medications, 
prescribing practices of clinicians must reach a level 
that demonstrates expertise regarding the prescribing of 
SSRIs. Prescribers must be knowledgeable of the medication 
that they prescribe. They also must have an awareness of
4
the factors that affect their choice of medication or 
treatment. Essock (2002) researched antipsychotic 
prescribing practices. The researcher found the relative 
frequency of use of the various antipsychotic medications 
does not correspond to what is known about their relative 
effectiveness for the treatment of schizophrenia. This 
leads one to ask how much prescribing patterns are 
influenced by pricing, order of introduction, ease of use, 
prescribers' idiosyncratic beliefs, marketing efforts, 
local cultures, and other factors beyond medication 
effectiveness (Essock, 2002). The researcher determined 
the variation of prescribing practices was widespread. 
Essock (2002) recommended that guidelines and performance 
monitoring must be implemented to reveal the influences 
that are defining one's prescribing practices.
Shell (2001) conducted a study concerning the 
antidepressant prescribing practices of nurse 
practitioners in the primary care setting. About one third 
of the patients seen weekly in the study were suffering 
from mental health conditions. This finding was equivalent 
to other findings suggesting that primary care providers 
are diagnosing and treating mental health disorders 
(Shell, 2001). According to Shell (2001), several findings 
conflict with established practice guidelines for the 
selection and prescribing of antidepressants, including
5
the antidepressants prescribed most often, antidepressant 
selection criteria, and the average length of 
antidepressant therapy. Shell (2001) recommended the need 
for further education of nurse practitioners regarding 
antidepressant therapy as they are seeing an increasing 
number of mental health disorders in the primary care 
setting.
Researchers have identified only minimal empirical 
data of the prescribing practices of primary care 
providers in regard to SSRIs. This information is needed 
due to the growing use of SSRIs in the primary care 
setting. Primary care providers strongly impact the 
patient's outcome by implementing their individual 
prescribing practices. Patients must sense the expertise 
of their health care provider in diagnosing depression. 
Patients also must perceive that their health care 
provider is competent in prescribing SSRIs in the primary 
care setting. These data will lead to optimal diagnosing 
and treatment of depression.
Significance to Nursing
The current study has several implications for the 
primary care provider. Findings from this study will add 
to the small amount of research previously conducted 
regarding use of SSRIs in primary care practice. The
6
paucity of information in the literature regarding SSRI- 
prescribing practices of primary care providers has led to 
earnest inquiry concerning the competency of the 
prescribers. The findings of this study will add to the 
literature regarding the competence of primary care 
providers who prescribe SSRIs in their practice setting. 
This study explored the use of alternative forms of 
treatment and the methods that the primary care provider 
takes to arrive at the idea that a patient is suffering 
from depression.
This study will support the education of primary care 
providers in the prescribing of SSRIs. Non-psychiatric 
providers see three fourths of patients treated in family 
practice clinics for depression (Lewis, 2000). Therefore, 
it is crucial that all primary care providers are 
effective in diagnosing and treating of depression.
Findings from this study may indicate a need for 
increasing the amount of time spent on prescribing 
medications, such as SSRIs, in pharmacology courses. As 
the use of SSRIs continues to escalate, an increased 
knowledge base concerning SSRIs will be necessary in both 
medical and nursing schools in order to give patients 
optimal care.
The use of SSRIs related to nursing practice is also 
of importance. In addition to increased knowledge
7
concerning SSRIs in primary care practice, this study may 
encourage those in primary care to evaluate their 
competency in prescribing SSRIs. Awareness regarding the 
benefits and contraindications of prescribing SSRIs in 
primary care may lead to safer clinical practices. This 
gain in knowledge also may contribute to the development 
of protocols regarding the prescribing of SSRIs in the 
primary care setting.
Theoretical Framework
The theoretical framework for this study was Benner's 
(2001) Novice to Expert Model. Benner applied a model of 
skill acquisition to nursing practice. The model is 
composed of five levels that nurses experience to attain 
expertise in the field of nursing. These five levels of 
skill include novice, advanced beginner, competent, 
proficient, and expert. These levels also are applicable 
to physicians.
Novice. A novice is a beginner. The beginner has not 
experienced the situation that he or she is expected to 
perform. A novice can be related to the primary care 
provider who is not familiar with SSRI-prescribing 
practices because of a lack of exposure to the client 
population that would require an SSRI. The novice.
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therefore, remains innocent of possessing prescribing 
practices of SSRIs.
Advanced beginner. The advanced beginner requires 
prior experience of the situation. He or she must have 
grasped the meaningful aspects of the situation. After 
being exposed to these aspects, he or she should be 
capable of displaying the amateur abilities in a 
situation. Primary care providers learn about prescribing 
SSRIs throughout their education preparation. They 
continue to learn about the process of prescribing SSRIs 
throughout the establishment of their career as they are 
exposed to patients meeting criteria that warrant an SSRI. 
At this level, the primary care provider begins to impact 
the client's care through increased knowledge and 
experience. They begin to relay what they have learned to 
their client.
Competent. Competence is exemplified by the primary 
care provider who has been working in the same situation 
or setting for 2 to 3 years. At this level, the primary 
care provider can implement a plan for the patient after 
contemplating the problem. The primary care provider is 
also conscious of long-term goals. This level is 
consistent with the process of primary care providers 
being aware of their personal prescribing practices of 
SSRIs and the factors that influence the practices.
9
Proficient. At the proficient level, the primary care 
provider learns through experience what outcome to expect 
in relation to different situations. As the primary care 
provider anticipates the outcome of a certain situation, 
he or she also is capable of originating a plan to aid in 
dealing with the issue at hand. A primary care provider at 
the proficient level would be able to look at the patient 
holistically and begin to develop a plan of care in 
accordance with the signs and symptoms that the patient is 
presenting. In relation to this study, a primary care 
provider at this level would be confident in diagnosing 
depression and would begin to incorporate his or her 
knowledge of SSRIs to the patient's plan of care.
Expert. The expert no longer depends on analytical 
decision making. After many years of experience, the 
expert has the ability to zero in on the problem at hand 
through intuition. This avoids dissipated considerations 
of alternative diagnosis and treatment options. Primary 
care providers prescribing SSRIs for their clients at this 
level are aware of their personal prescribing practices 
and the factors that influence them. They are able to 
prescribe an SSRI when they deem it is appropriate for the 
diagnosis they have devised. As primary care providers 
attain this level of SSRI prescribing, their practices 
have a direct impact on the outcome of the patient.
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The focus of Novice to Expert was the process of 
ultimately gaining the knowledge and experience needed to 
become a confident and competent primary care provider. 
This can be accomplished by the primary care providers 
increasing their knowledge of SSRIs. Also, the primary 
care provider should review their own SSRI-prescribing 
practices that have developed over time and be aware of 
the factors that influence them. The ultimate goal of this 
process is to achieve the optimal outcome for the client.
Assumptions
For the purpose of this study, the following 
assumptions were made :
1. SSRI-prescribing practice is a phenomenon that 
occurs in primary care and is empirically measurable.
2. Primary care providers prescribe SSRIs based on 
the provider's perceived level of competence.
Statement of the Problem
The use of SSRIs has become prevalent in primary care 
settings across the United States. An increased number of 
clients with a diagnosis warranting an SSRI are being seen 
in the primary care setting. As these numbers continue to 
increase, researchers have identified only minimal 
empirical data regarding the SSRI-prescribing practices of 
primary care providers. Ongoing investigation of SSRI-
11
prescribing practices by health care providers is needed 
to ensure safe practices and favorable client outcomes.
Research Questions
This study was guided by the following research 
questions :
1. What are the factors that influence the 
prescribing practices of primary care providers regarding 
SSRIs?
2. What is the perceived competency level of primary 
care providers in prescribing SSRIs?
Definitions of Terms
The terms defined for this research study were as 
follows :
Factors: Theoretical : any of the conditions, etc. 
that bring about a result {Webster's New World Dictionary,
2002) . Operational : any condition that brings about a 
result of influencing a primary care provider to choose 
one treatment over the other as defined by the Dowell 
Prescribing Questionnaire.
Prescribing practices: Theoretical: the process 
undergone in which one orders or advises the use of a 
medicine or treatment {Webster's New World Dictionary, 
1995). Operational: the process in which the primary care
12
provider orders or advises an SSRI as measured by the 
Dowell Prescribing Practice Questionnaire.
Primary care providers: Theoretical : an advanced 
practice nurse or medical doctor who is educated in the 
care of patients with emphasis in primary care (American 
Heritage Dictionary, 2002). Operational: those physicians 
and nurse practitioners educated to make health care 
services available in a primary care setting and are 
listed in a local public guide to physicians and nurse 
practitioners.
SSRIs: Theoretical: a class of drugs that inhibits 
the reuptake of serotonin by neurons of the central 
nervous system and are primarily used in the treatment of 
depression {American Heritage Dictionary, 2002). 
Operational: a class of drugs that inhibits the reuptake 
of serotonin by neurons of the central nervous system and 
are primarily used in the treatment of depression by 
primary care providers. This class includes the following: 
citalopram, fluvoxamine, paroxetine, fluoxetine, 
sertraline, and escitalopram.
Perceived competency level: Theoretical: the level at 
which one feels capable {Webster's New World Dictionary, 
1995). Operational: a primary care provider's level at 
which one feels capable of prescribing SSRIs as measured
13
in the participants' responses to questions 10-11 on the 
Dowell Prescribing Practice Questionnaire.
Summary
The SSRI-prescribing practices among nurse 
practitioners and physicians in a southeastern state are 
presently unknown. This study sought to determine the 
SSRI-prescribing practices of primary care providers in 
this area. In this chapter, an introduction to this 
research problem was provided. Benner's Theory of Novice 
to Expert was described as the theoretical foundation for 
the study.
Chapter II contains literature that was reviewed 
pertaining to this study. Chapter III explains the 
empiricalization of the problem and describes the setting, 
population, and sample. Chapter IV discusses the findings 
of the research data. Finally, in Chapter V an explanation 
of the findings and the conclusions drawn from the 
findings are revealed, along with implications for 
nursing.
Chapter II 
Review of the Literature
A review of the literature was conducted to explore 
the SSRI-prescribing practices in primary care. To date, 
research regarding this topic remains limited. SSRI use is 
growing in the field of primary care. Although many 
studies have been carried out concerning the use of SSRIs, 
no research studies were identified regarding the SSRI- 
prescribing practices of primary care providers.
Antidepressants are among the most frequently 
prescribed drugs in the world. In 2001, Shell conducted a 
study concerning the prescribing practices of 
antidepressants by nurse practitioners. The purpose of 
this study was to determine the factors nurse 
practitioners consider when prescribing an antidepressant, 
antidepressant-prescribing frequency by nurse 
practitioners, types of antidepressants prescribed by 
nurse practitioners, and health problems that nurse 
practitioners are treating with antidepressants. Shell 
also sought to determine nurse practitioners' perceived 
competence in choosing an appropriate antidepressant and
14
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their perceived need for further education about 
antidepressants.
The researcher implemented a survey design. The 
researcher developed a 2 6-item questionnaire that was used 
to attain information pertaining to the prescribing 
practices of nurse practitioners. The questionnaire was 
reviewed by a group of nurse practitioners selected by the 
researcher and revisions were made to the questionnaire in 
accordance with a small pilot study. The questionnaire was 
mailed to 108 nurse practitioners from Tennessee. They 
were randomly chosen from a database of 541 nurse 
practitioners. For the purpose of this study, the nurse 
practitioner must practice at least 30 hours a week in 
direct patient care and must have drug-prescribing 
privileges. A total of 70 questionnaires were returned, 
yielding a 65% return rate; 44 (63%) of the returned 
questionnaires met the study's inclusion criteria (Shell, 
2001). Data were analyzed using descriptive statistics. 
Shell (2001) found nurse practitioners reported writing 
between 1 and 100 prescriptions per week for 
antidepressants. The respondents were asked to give the 
average length of time, in consecutive weeks, that they 
prescribed treatment with antidepressants, and the 
response ranged from 6 to 52 weeks. Approximately half of 
the respondents (53%) reported consecutive treatment of 24
16
weeks or less, and 22% of the respondents reported 
consecutive treatment of 12 weeks or less (Shell, 2001). 
Factors influencing the practitioners' choice of 
antidepressant were measured on a Likert-type scale. The 
certain factors were ranked from no influence to most 
important. The results indicated efficacy (68%) and the 
nurse practitioner's knowledge of the antidepressant (42%) 
as being the most influential factors. Cost factors (61%), 
potential for drug interaction (66%), and the patient's 
associated medical conditions (66%) were ranked closely 
behind as being very important. Media advertising (72%) 
and pharmaceutical promotional efforts (55%) were found to 
be of minimal influence on a nurse practitioner's choice 
of an antidepressant. The most frequently prescribed 
antidepressants by the respondents were Prozac (43%) and 
Paxil (39%). The most frequent mental health disorders 
treated by the respondents were depression (91%) and 
social phobia/panic (45%). Seventy-one percent of the 
practitioners involved in the study felt confident in 
choosing the antidepressant best suited for the patient's 
condition. Twenty-nine percent did not feel comfortable 
with choosing an antidepressant. The study also revealed 
that 56% of the respondents felt that they needed to be 
further educated on antidepressants. It was found that 
when prescribing antidepressants, there was a variation
17
among the respondents and their prescribing practices and 
in some cases variation from established guidelines.
Shell (2001) concluded that nurse practitioners 
frequently treat mental health disorders and prescribe 
antidepressants for a variety of health disorders. The 
results of the study indicate that nurse practitioners 
need more education about the appropriate selection and 
use of antidepressants (Shell, 2001) . Shell also concluded 
that nurse practitioners need to seek continuing education 
on antidepressants and adhere closely to established 
practice guidelines on antidepressant use and treatment of 
depression.
The findings of this study are important to the 
current study because the type of research implemented by 
Shell is congruent with the type of information this 
researcher is seeking: primary care providers and their 
prescribing practices with SSRIs. Assessing the 
prescribing practices of antidepressants by nurse 
practitioners is very crucial in optimally caring for 
patients in the primary care setting.
Another study, Stafford, MacDonald, and Finkelstein 
(2001), reported more than 19 million adults are affected 
annually by depression in the United States. Depression 
can be adequately treated with medications. Antidepressant 
pharmacotherapy assists between 65% and 7 5% patients in
18
dealing with depression. There are three classes of 
antidepressants: tricyclic and related cyclic 
antidepressants (TCAs), monoamine oxidase inhibitors 
(MAOIs), and selective serotonin reuptake inhibitors 
(SSRIs). Among these medications, SSRIs have the most 
favorable side affect and safety profiles, characteristics 
likely to increase their prescription by physicians and 
continue use by patients (Stafford et al., 2001). In 2001, 
Stafford et al. investigated trends in antidepressant use, 
as well as broader changes in depression treatment, 
following the availability of SSRIs.
Data used in this study originated from the National 
Disease and Therapeutic Index (NDTI), a continuing 
physician survey conducted by IMS HEALTH. The NDTI 
provides information pertaining to the diagnostic and 
prescribing information of patients seen in clinics 
throughout the United States. A random sample of office- 
based physicians stratified by specialty was selected from 
the masterlists of the American Medical Association 
(Chicago, IL) and the American Osteopathic Association 
(Chicago, IL) (Stafford et al., 2001). Practice patterns 
are revealed using this sample. The sample population 
consisted of approximately 3,500 physicians. Each 
physician was assigned a 2-day data collection period each 
quarter. Data for this study were collected from NDTI
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reports gathered from 1987 through the third quarter of 
2001. Stafford et al. (2001) selected visits by patients 
reported to have depression-related diagnosis. Outcomes 
examined included the frequency of depression visits, the 
likelihood of antidepressant therapy, and the use of 
specific medications (Stafford et al., 2001).
Data were analyzed using descriptive statistics. The 
number of patients reporting depression during an office 
visit increased from 14.4 million a year in 1987 to 24.5 
million a year in 2001. In accordance with these results, 
other variations occurred. The number of visits made to 
psychiatrists declined from 44% of visits in 1987 to 29% 
in 2001. The number of visits to primary care physicians 
also increased during this time period from 50% to 64%.
The ages of patients also decreased. The most evident 
decline was in the age group of 65 and older. Women 
consistently made up two thirds of the patients seen 
during this time period. Stafford et al. (2001) determined 
that among patients reported to have depression, the rate 
of antidepressant medication treatment steadily increased 
from 70% of patients in 1987, 76% in 1990, 87% in 1996, 
and 89% in 2001. In 1987, tricyclic antidepressants (TCAs) 
were used most often in treating depressed patients. 
Physicians reported the use of a TCA in 47% of visits by 
patients with depression, with Amitriptyline (14% of
20
depression patients), doxepin (7.7%), and desipramine 
(63%) the most commonly prescribed TCAs (Stafford et al., 
2001). The most common non-TCA antidepressant during this 
time was trazedone. It was reported as being used 12% of 
the time in 1987. The first SSRI, fluoxetine, was 
introduced in January of 1998. During the first year 
fluoxetine was on the market, 9.7% of patients with 
depression received the drug (Stafford et al., 2001). The 
following year, fluoxetine was prescribed to 21% of 
depressed patients seen. SSRI use increased to 46% by 
1993. This occurred after two other SSRIs were introduced; 
sertraline was introduced in 1992 and paroxetine in 1993. 
Subsequent release of venlafaxine (1994), fluvoxamine 
(1995), and citalopram (1998) increased SSRI use still 
further to 53% in 1994, 64% in 1997, and 69% in 2001 
(Stafford et al., 2001). As the use of SSRIs increased, 
the use of other antidepressant medications decreased. The 
use of TCAs decreased from 47% in 1987 to 2.1% in 2001.
The MAOIs have been used very little throughout the time 
period researched. Benzodiazepines also have declined from 
use. In 1987, 21% of depressed patients were treated with 
benzodiazepines. In 2001 only 2% were treated with 
benzodiazepines.
The methods of managing depression went through 
significant changes from 1987 to 2001. Stafford et al.
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(2001) concluded that the increasing therapeutic dominance 
of SSRIs may have contributed to other changes in 
depression treatment, including declining benzodiazepine 
use, increased aggregate antidepressant treatment rates, 
and increased reporting of depression. The authors of this 
study suggest that SSRIs side effect profiles and the 
perceived effectiveness of SSRIs may be the contributing 
factors to the above changes.
The introduction of SSRIs has brought many changes to 
the prescribing practices of physicians who manage 
depression. The findings of this study are important to 
this current author's application of research study 
because of the impact that SSRIs made on the prescribing 
practices of medications used for depression. Stafford et 
al.'s study also is important to this author's study 
because the findings reveal the increased use of SSRIs in 
the United States. Thus, there is the need for further 
research concerning the prescribing practices of SSRIs.
Stafford, Ausiello, Misra, and Saglam (2000) reported 
depression as the number one cause of morbidity in the 
United States. The primary care role in treating 
depression has been altered due to the changes in the 
organization of health care. Insurance companies have been 
discouraging health care providers from referring patients 
with depression to a specialist. As a result, almost half
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of all patients with affective disorders are seen in 
primary care settings (Stafford et al., 2000). Primary 
care providers have access to treatment of depression, but 
past studies have signaled that depression is 
underdiagnosed and undertreated by this group of health 
care professionals. Other studies, however, suggest that 
primary care physicians have begun to meet the new 
challenges they face in the treatment of depression 
(Stafford et al., 2000). In 2000, Stafford et al. sought 
to expand on the existing literature by investigating the 
use of pharmacotherapy and counseling by primary care 
physicians to examine whether improvements in depression 
management have continued.
Stafford et al. (2000) reported that 1,322 primary 
office visits by patients reported to have depression were 
analyzed. Data were collected by an ongoing survey that 
ensures random, stratified sampling by geographic area and 
specialty. The patients were 18 years of age and older and 
were seen by internists, general practitioners, or family 
physicians. The patterns of medication and physician 
counseling were examined. Antidepressants were categorized 
into one of the following classes: MAOs, TCAs, SSRIs, or 
other antidepressants (including bupropion, trazodone, or 
the nonspecific designation "antidepressant agent"). The 
authors reported that their assessment of counseling
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practices focused on the report of either psychotherapy or 
mental health counseling during physician visits. The 
patients' diet, exercise, weight reduction, injury 
prevention, and smoking cessation were also evaluated 
because the presence of depression may complicate the 
management of these issues. Independent predictors of 
depression therapy were examined using multiple logistic 
regression. Where informative, the authors compared the 
practices of primary care physicians with those of 
psychiatrists.
For each visit record, the National Center for Health 
Statistics provided a visit weight calculated from the 
physician and visit sampling rates, adjusted for 
nonresponse. Statistical aggregation using these visit 
weights allowed the researchers to estimate the national 
volume of clinical activities among office-based 
physicians. These weights were further modified by 
proportional scaling to provide "effective sample sizes." 
Using SAS, bivariate differences were tested using the 
chi-square test with a p value < .05 signifying 
statistical significance (Stafford et al., 2000).
Stafford et al. found that 7.8% of the primary care 
office visits were related to a diagnosis of depression. 
Antidepressants (42%) were found to be the most common 
form of treatment, followed by psychotherapy/mental health
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counseling (28%) and benzodiazepines (21%). SSRIs (25.8%) 
were found to be the most prescribed antidepressant by 
primary care providers. TCAs (10.7%) and other 
antidepressants (7.9%) were the next most commonly 
prescribed medications.
SSRI use for depression was reported more frequently 
among patients 18 to 44 years old (33.3% of all depression 
visits) compared with those 45 to 64 years old (20.6%) and 
patients 65 years or older (23.0%, p < .001). Among the 
different primary care specialties, SSRIs were noted more 
often by family physicians (32.8%) than by internists 
(22.6%) or general practitioners (19.2%, p < .001). TCA 
use was not significantly related to patient age. General 
practitioners prescribed TCAs more often (23.4%) than 
internists (8.3%) or family physicians (6.4%, p < .001) 
(Stafford et al., 2000).
The use of benzodiazepines and antidepressants varied 
among primary care specialty. The use of benzodiazepines 
was influenced by health insurance and geographic region. 
The researchers found that psychiatrists reported 
psychotherapy/mental health counseling (88%) most 
frequently, followed by antidepressants (64%) and 
benzodiazepines (25%).
The predominant use of SSRIs suggests that primary 
care physicians have begun to adopt new therapeutic
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strategies for depression. Furthermore, the researchers 
found the frequent use of benzodiazepines disturbing. In 
59% of the visits to primary care physicians, where 
depression was diagnosed and benzodiazepines were ordered, 
anxiety was not addressed. Stafford et al. (2001) found 
the overall use of antidepressants to be significantly 
lower in comparison to prior studies.
This study is of significance to the author's study 
because this type of research is parallel with the type of 
research that the author is implementing. The frequent use 
of SSRIs in primary care reported in this study is also of 
great interest to the researcher, considering the SSRI 
prescribing practices of primary care providers was the 
focus of the current researcher's study. These researchers 
also reported that psychiatrists prescribed 
psychotherapy/mental health counseling more often than 
they prescribed a medication. This is also of interest to 
the current author.
Ferguson (2000) conducted a study to review the 
diagnosis and treatment of depression in primary care. 
Depression, one of the most common disorders in the 
primary care setting, is a serious mental illness with an 
estimated lifetime prevalence rate of 17%. Many patients 
with depression first seek help from their primary care 
physician, complaining of a variety of somatic symptoms
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that actually mask a depressive disorder (Ferguson, 2000). 
Patients may return repeatedly to their primary care 
physician seeking resolution of their symptoms, but, 
despite these repeated visits, only 50% of patients with 
depression who are seen in the primary care setting will 
be accurately diagnosed, and, of these, less than 10% will 
be appropriately treated (Ferguson, 2000).
Ferguson reviewed relevant articles on depression 
retrieved from Medline. They were classified into the 
following categories: diagnosis and screening, 
nonpharmacologic therapy, pharmacologic therapy, newer 
antidepressant agents, and maximizing antidepressant 
therapy. The importance to primary care practice was 
considered in determining the significance of each article 
reviewed.
Ferguson (2000) reported that because no laboratory 
tests exist for depression and no biological markers can 
be measured routinely, the diagnosis of depression must be 
made with a number of reliable depression scales and 
questionnaires that can be completed quickly in the 
primary care setting (e.g., Zung Self-Rating Depression 
Scale, Beck Depression Inventory, or Geriatric Depression 
Scale).
The goal of depression treatment is to lead the 
patient to recovery and alleviate all symptoms. Treatment
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should encompass methods that rapidly relieve symptoms 
(e.g., pharmacotherapy) and prevent relapse and recurrence 
(e.g., nonpharmacologic therapy and or pharmacotherapy). 
Advances in the treatment of depression, which include new 
agents with dual mechanisms of action and a broader 
spectrum of efficacy across affective and anxiety 
disorders, make these goals obtainable (Ferguson, 2000). 
The researcher identified the need for psychotherapy and 
patient education when treating a patient with major 
depressive disorder. Psychotherapy includes cognitive, 
behavioral, and interpersonal therapy. This type of 
therapy must be performed by a qualified mental health 
professional. The primary care physician can perform a 
counseling role by providing the patient with support and 
insight, offering alternative explanations, and making 
recommendations. The primary care physician may also 
educate the patient on the biochemical nature of 
depression and reassure the client that the symptoms are 
not due to a personal weakness.
Increased knowledge about the diagnosis and treatment 
of depression has greatly enhanced the ability of the 
primary care physician to provide safe and effective 
pharmacological therapy (Ferguson, 2000). Ferguson 
reported that TCAs and MAOIs are no longer considered the 
treatments of choice because of the severity of side
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effects and the potential for fatalities. SSRIs have been 
found to have fewer side effects and are tolerated better 
than TCAs and MAOIs.
Patients are capable of attaining remission with the 
appropriate treatment. To ensure that patients attain 
remission and have a low risk of relapse and recurrence, 
pharmacotherapy should be maintained at the maximum 
tolerated dose for at least 4 to 9 months. Thereafter, 
long-term maintenance therapy should be instituted to 
prevent the development of a new episode (Ferguson, 2000).
Ferguson concluded that patients can be diagnosed 
rapidly with any one of several reliable questionnaires 
that can be administered at the office. These 
questionnaires should become a routine part of the primary 
care physician's practice, much like blood pressure 
monitoring (Ferguson, 2000). Once a diagnosis is reached, 
the appropriate therapy must be selected. An understanding 
of the risk-benefit profiles, adverse events, drug-drug 
interactions, and onset of action of these antidepressant 
agents is critical for appropriate management of depressed 
patients (Ferguson, 2000).
Ferguson's (2000) study relates to the current 
researcher's endeavor, which focused on the prescribing of 
SSRIs for depression treatment in primary care. Ferguson 
(2000) concluded that depression is one of the most common
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disorders treated in primary care today. The author 
reported that patients can be treated safely and 
successfully in the primary care setting with 
pharmacological treatment, if adequately diagnosed. The 
current author's study congruently sought to reveal 
diagnostic methods and treatment options concerning the 
prescribing of SSRIs in primary care.
Dowrick, Gask, Perry, Dixon, and Usherwood (2000) 
sought to determine if general practitioners' (GPs) 
attitudes toward depression predict their clinical 
behavior. General practitioners' attitudes toward 
depression vary, as do their abilities to detect and 
manage it effectively (Dowrick et al., 2000). The 
researchers tested two hypothesis: (a) That questionnaire
measures of GPs' confidence in identifying depression 
predict their ability to identify depression in their 
patients and (b) that GPs who prefer antidepressants 
prescribe more than those who prefer psychotherapy.
Depression is a common and disabling condition, for 
which the overwhelming majority of medical care is 
provided by general practitioners. The Depression Attitude 
Questionnaire (DAQ) has been designed within this context 
as an instrument to enable researchers to measure doctors' 
attitudes to depressive illness, and thereby as a means to 
orientate educational effort (Dowrick et al., 2000). The
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DAQ is a self-completion instrument consisting of 20 
questions. Answers are analyzed using a visual analogue 
scale. Factor analysis indicated that 17 of the items fall 
into 4 principal components. These components include 
attitudes toward treatment, professional unease, 
depression malleability, and identification of depression. 
The DAQ has been promoted as a valid and reliable measure 
of the attitudes of GPs toward depression (Dowrick et al., 
2000).
Forty GPs completed the DAQ and were asked for 
prescribing information. Between November 1996 and March 
1997, two research assistants undertook waiting-room 
surveys of consecutive attenders at each of these GP's 
offices (Dowrick et al., 2000). Attenders ranged from age 
16 to 65 years. They were asked to answer the 12-item 
General Health Questionnaire (GHQ-12). After the 
consultation, the GP rated each patient on the severity of 
psychological disturbance along a 5-point Likert scale 
ranging from "no disorder" to "severe disorder." The DAQ 
was also completed by the GPs. The GPs also agreed to have 
their prescribing patterns reviewed by the research team. 
From a comparison of the GHQ-12 and doctor rating scores 
for each patient, it is possible to make three differing 
assessments of a doctor's ability to diagnose depression
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and related psychological disorders, in terms of 
identification, accuracy, and bias (Dowrick et al., 2000).
Dowrick et al. (2000) reported a total of 1,436 
general practice attenders. All 40 general practitioners 
completed the DAQ and achieved adequate numbers of 
severity ratings to allow identification, accuracy, and 
bias ratings to be calculated for each GP. Component 1 
scores were grouped around the mean, while the Component 3 
depression malleability scores were skewed to the left.
The mean DAQ score for Component 3 suggests that most of 
the general practitioners did not believe that depression 
was an inevitable condition, while the scores for the 
other three components indicated a more even distribution 
of attitudes. The researchers indicated that GPs who felt 
comfortable with depression were more likely to identify 
it accurately. Similarly, GPs who considered that 
depression is a malleable condition were more likely to 
identify it accurately. However, there were significant 
associations between observed diagnostic ability and 
preference for psychotherapy, ease in managing depression, 
and belief in successful treatment.
PACT data (prescribing information) was available for 
26 (65%) of the GPs for the time period of the study. The 
mean number of anxiolytics and hypnoticé during this time 
was 203. The average number of prescriptions written for
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antidepressants at this time was 207. Among the 
antidepressants, the mean number of prescriptions issued 
for tricyclics was 118, versus 86 for the SSRIs. An 
association was found between the GPs' attitudes toward 
treatment and the prescribing of SSRIs. No association was 
detected between the other three components of the DAQ and 
the GPs' number of prescriptions for antidepressants in 
general or either tricyclics or SSRIs in particular.
Dowrick et al.'s (2000) study demonstrated the 
influence that general practitioners' attitudes have on 
their treatment of depression. The current study focused 
on the SSRI prescribing practices of primary care 
providers when treating depression. It is important to 
understand what factors influence health care providers 
when making treatment choices.
Patients with depressive symptoms are more likely to 
seek help in the primary care setting than any other 
health care environment. Observational studies continue to 
demonstrate, however, that the outcomes of patients with 
depression managed in primary care are less than optimal. 
Disease detection rates are low, the intensity of 
treatment is usually inadequate, and patients are often 
left with significant clinical and functional impairments 
(Finley et al., 2002). In 2002, Finley et al. carried out 
an investigation to study the effect of a clinical
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pharmacy specialist working along with primary care and 
psychiatry in the treatment of depression.
This investigation was conducted at KPMCSR, a medium­
sized primary care facility within a large nonprofit staff 
model health maintenance organization (HMO). The clinic is 
staffed by approximately 30 primary care physicians (28 
physicians and 2 nurse practitioners) and provides medical 
care to over 52,000 members (Finley et al., 2002).
Thirteen PCPs referred eligible patients to the 
intervention group. The two pharmacists involved in the 
study had their doctor of pharmacy degrees and had 
experience in direct patient care. The pharmacists were 
given limited prescribing privileges. They were granted 
permission to modify medications previously prescribed for 
the patient and to add ancillary medications if needed.
The pharmacists were required to notify the PCP before 
making changes to the treatment regimen.
The patient population consisted of HMO members who 
were identified by their PCP as suffering from depression 
and subsequently received prescriptions for antidepressant 
medications for this purpose. Patients in the control 
group consisted of HMO members who were treated for 
depression with antidepressants by the remaining 17 PCP at 
this facility in accordance with the usual standard of 
care (Finley et al., 2002). Demographic variables.
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treatment patterns, sex, age, and medical co-morbidity 
were reviewed.
The 13 providers who participated in the 
collaborative practice model were encouraged to refer all 
patients diagnosed with depression and started on 
antidepressant medications to the pharmacist-managed 
clinic for medication management and follow-up (Finley et 
al., 2002). The PCP notified the pharmacists at the 
conclusion of each index visit. The pharmacists 
interviewed the patient on the day the antidepressant was 
prescribed. This interview was congruent with a 
psychiatric interview. The first half of the interview 
gathered data concerning symptoms, current environmental 
stressors, previous mental health history, medical 
history, social history, and family history. The latter 
half of the interview was devoted to patient education 
regarding the nature of depression as an illness 
(predisposing factors, natural course, prognosis, and 
anticipated recovery process), pharmacological treatment 
for depression (potential adverse effects, drug 
interactions, therapeutic response pattern, and duration 
of treatment), and the importance of adhering to the 
treatment (Finley et al., 2000). Patients were followed by 
return visits and telephone calls.
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Baseline differences between the treatment and 
control groups were compared using Student's t test for 
continuous data and the chi-square test for categorical 
data (Finley et al., 2000). The baseline 6-week and 
baseline 24-week values were compared using a Student's t 
test.
The intervention group consisted of 91 patients.
There were 12 9 patients identified in the control group. 
Analysis of the antidepressant initially prescribed by 
PCPs at baseline revealed that the vast majority of 
patients in both groups received SSRIs, 85.1% in the 
intervention group versus 92.2% in the control group, with 
starting doses slightly lower in the intervention group 
(Finley et al., 2000). Both groups expressed satisfaction 
in their overall care.
Finley et al. (2000) reported that a collaborative 
practice model in which clinical pharmacy specialists 
worked with PCPs and managed the medication therapy of 
patients with mild to moderate depression for 6 months 
increased patients' adherence to treatment and their 
satisfaction and reduced the patients' subsequent visits 
to PCPs.
Finley et al.'s study related to the current 
researcher's endeavor because from data reviewed it was 
evident that SSRIs are frequently used in treating
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depression in primary care. This study provided evidence 
that intense management is needed when treating depressed 
patients in primary care. The patients' complete medical, 
social, and family history needs to be obtained. Finley et 
al. (2000) also discovered that education of patients 
concerning depression and their treatment plays a major 
role in patients' compliance.
Summary
From the review of literature, it is evident that 
SSRI usage is steadily increasing in the primary care 
setting. The review of literature supported the importance 
of researching the antidepressant prescribing practices of 
primary care providers. Researchers compared the 
prescribing practices of primary care providers to that of 
psychiatrists. Differences were noted, signaling the need 
for the investigation of primary care providers' SSRI- 
prescribing practices. Treatment options of depression 
were researched, along with other methods of managing this 
disorder. The review of literature also gave insight on 
the competence level of primary care providers. Primary 
care providers should be highly educated in the arena of 
depression and the treatment options in order to optimally 
care for their patients.
Chapter III 
The Method
The purpose of this study was to determine the SSRI- 
prescribing practices of primary care providers. 
Empiricalization of the problem will be described in this 
chapter. The setting, population, and sample will be 
described, and the methods utilized to collect the data 
will be explained.
Design of the Study
A descriptive survey research design was implemented 
to identify the SSRI-prescribing practices of primary care 
providers. Gillis and Jackson (2002) defined a descriptive 
design as research that identifies and describes concepts 
and phenomena of interest to nursing. This research design 
was appropriate because the purpose of the research was to 
identify the SSRI-prescribing practices of primary care 
providers. No manipulation of variables occurred.
Setting, Population^ and Sample
The setting for the study was primary care health 
sites in a southeastern state. The target population
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consisted of 2,000 physicians and nurse practitioners who 
practice in a primary care setting and who are listed in a 
public physician and nurse practitioner directory. A quota 
sampling method was used to reduce the target sample size 
to 100. Surveys were sent to the first 50 physicians and 
the first 50 nurse practitioners listed as primary care 
providers. The final sample consisted of those primary 
care providers who responded to the survey and returned 
the questionnaires.
Instrumentation
Two instruments were used to collect data for the 
study. The first instrument was the researcher-designed 
Demographic Survey, which was used to assess 
characteristics of the sample (see Appendix A). The survey 
consisted of five questions that participants were 
instructed to check or to fill in the most appropriate 
responses. Items were constructed to elicit information 
pertaining to the specific profession and to the length of 
practice of the participant.
The second research instrument was the researcher- 
designed Dowell Prescribing Practice Questionnaire, which 
was utilized to assess SSRI-prescribing practices of 
primary care providers (see Appendix B). This 
questionnaire contained 11 questions, which participants
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were instructed to check the most appropriate responses. 
Some examples of questions on the questionnaire are as 
follows: In your role as an MD or NP, approximately how 
many patients do you see per day? What methods do you use 
to diagnose depression? What treatments other than an 
antidepressant do you prescribe? And what factors 
influence which SSRI you choose? Questions 3, 6, and 8 
allowed the participant to fill in their response if it 
was not listed as an answer choice. A numerical coding 
scheme was implemented in order to score the data. Answer 
choices were assigned a number code and then arranged on a 
graph in accordance with each individual question. 
Perceived competency was assessed using items 10 and 11 on 
the Dowell Prescribing Practice Questionnaire. A Likert 
scale ranging from not competent to very competent was 
utilized. Estimated time to complete the instruments was 
10 minutes.
Data Collection Procedure
Protection of the rights of human subjects was 
achieved by seeking approval to conduct the study from the 
Mississippi University for Women Committee on Use of Human 
Subjects in Experimentation (see Appendix C). Packets were 
collated and consisted of a letter of introduction and 
information concerning consent (see Appendix D) the
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Demographic Survey, the Dowell Prescribing Practice 
Questionnaire, and a self-addressed, stamped envelope. 
Packets were mailed to 50 primary care physicians and 50 
family nurse practitioners in a southeastern state. The 
introduction letter advised participants that there were 
no risks in participating in the study. The participants 
were assured of anonymity by not being required to place 
their name on the data sheets. Two weeks after the 
questionnaires were sent out, reminder postcards were sent 
(see Appendix E), Consent was assumed from each 
participant by their completion and return of the 
Demographic Survey and the Dowell Prescribing Practice 
Questionnaire.
Data Analysis
Data from this study were analyzed using descriptive 
statistics including means, frequency, distributions, and 
percentages. Content analysis was used to detect common 
themes in the data retrieved from questions 3, 6, and 8 if 
participants chose to list information not included as an 
answer choice. Questions 10 and 11 were analyzed using 
percentages.
Summary
In this chapter, the empiricalization of the research 
study, which examined the SSRI-prescribing practices among
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primary care providers in a southeastern state, was 
explained. The design of the study, the setting, the 
population, and the sample were described. The 
instrumentation and methods of data collection were 




The purpose of this study was to determine the SSRI- 
prescribing practices among nurse practitioners in a 
southeastern state. A descriptive research design was 
implemented. The researcher-developed Demographic Survey 
and the Dowell Prescribing Practice Questionnaire were 
utilized to collect information from nurse practitioners 
and physicians regarding their SSRI-prescribing practices. 
Data from each question were analyzed using descriptive 
statistics. The findings from the study are presented in 
this chapter.
Description of the Sample
A total of 100 surveys were mailed to primary care 
providers in a southeastern state. The packet contained 
the Demographic Survey and the Dowell Prescribing Practice 
Questionnaire. The Demographic Survey consisted of five 
questions. The respondents were asked to check their 
response to three of the questions and fill in the 
appropriate response to answer the other two questions.
42
43
The Dowell Prescribing Practice Questionnaire was made up 
of 11 questions. Thirty surveys were completed and 
returned to the researcher.
The ages of respondents ranged from 29 to 70 years. 
The average age was 43 years. The reported length of time 
practicing ranged from 2 to 4 6 years. The average length 
of time practicing was 9.9 years. Responses to the other 
demographic survey questions are presented in Table 1.
Table 1
Demographic Data Reported by Primary Care Providers 










Medical doctor 9 30.0
Nurse practitioner 21 70.0
Note. Percentages rounded to the nearest 10̂  ̂
=30.
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Findings Related to the Research Questions
Two research questions guided this study. The first 
research question was as follows: What are the factors 
that influence the prescribing practices of primary care 
providers regarding SSRIs? The second research question 
was as follows : What is the perceived competency level of 
primary care providers in prescribing SSRIs? Item 1 on the 
Dowell Prescribing Questionnaire was designed to assess 
how many patients the respondent sees per day. Responses 
to item 1 can be found in Table 2.
Table 2
Patients Seen Per Day by Primary Care Providers Expressed 
in Frequency and Percentage
No. of patients %
Less than 10 0 0.0
10 to 15 2 7.0
16 to 20 5 17.0
21 to 25 5 17.0
26 to 30 10 33.0
More than 30 8 27.0
Note. Percentages were rounded to the nearest 10̂  ̂
^N = 30.
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Item 2 was designed to find the percentage of 
patients seen that suffer from depression. Among the 
respondents, 8 (27%) answered less than 15%, 16 (53%) 
answered 25%, 5 (17%) answered 50%, 1 (3%) answered 75%, 
and none of the respondents answered more than 75%.
Item 3 was utilized to find what methods the primary 
care providers are using to diagnose depression. 
Respondents were encouraged to check all that apply as 
well as to write in additional methods. The most common 
methods for diagnosing depression may be seen in Table 3.
Table 3
Most Common Methods Used to Diagnose Depression Expressed 
in Frequency and Percentage
Diagnosing method %
DSM-IV criteria 15 50.0
Established quantitative
screening tool for depression 13 43. 0
Patient states, "I am depressed." 20 67.0
Patient presents with symptoms 
of depression 28 93.0
Other 9 30.0
Note. One respondent failed to respond. Respondents were asked 
to select as many diagnosing methods as applied and to write in 
other methods if they were not included in the list. Additional 
methods that were listed are as follows: Zung Depression Scale, 
in-house questionnaire, family history of mood disorders, known 
somatization, refer to in-house therapist, how patients present 
to office, patients' state of mind, and SIGE CAPS questionnaire.
'N = 30.
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Item 4 was designated to determine the percent of 
patients treated with an SSRI, considering the number of 
patients the responders treat for depression. Respondents 
were asked to choose the percentage that reflected their 
prescribing practices. There were only 29 responses to 
this question. Results of item 4 are presented in Table 4
Table 4
Percentage of Patients Treated 
and Percentage
with an SSRI by Frequency
Percent treated with SSRI f̂ %




More than 75 11 38.0
Note. Percentages were rounded to the nearest 10̂ .̂
^N = 30.
Item 5 was designed to assess the most often 
prescribed SSRI to the least prescribed SSRI. Respondents 
were asked to rank the six SSRIs in order of their most 
prescribed to the least prescribed. Escitalopram was the 
most often prescribed SSRI, while fluovoxamine was the
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least often prescribed. Responses to item 5 are presented 
in Table 5.
Table 5
Frequently Prescribed SSRIs Expressed in Frequency and Percentage
SSRI
1* 2 3 4 5 6̂
f % f % f % f % f % f %
citalopram 3 12.0 1 27.0 5 19.0 6 23.0 5 19. 0 0 0.0
fluovoxamine 0 0.0 0 0.0 0 0.0 0 0.0 4 15.0 22 85.0
paroxetine 6 23.0 8 31.0 11 42.0 0 0.0 1 4.0 0 0.0
fluoxetine 2 8.0 1 4.0 3 12.0 3 12.0 16 62.0 1 4.0
sertraline 6 23.0 9 35.0 3 12.0 6 23.0 2 8 . 0 0 0.0
escitalopram 8 31.0 5 19.0 7 27.0 1 4 . 0 5 19. 0 0 0.0
Note. Only 26 respondents ranked all six drugs on this question. 
Incomplete rankings of the drugs are not included in this table.
®1 = Most often prescribed. ^6 = Least often precribed.
Item 6 was designed to assess what factors influence 
which SSRI a primary care provider chooses. Responses to 
item 6 can be found in Table 6. Findings revealed that 
side effects of the medication were most influential.
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Table 6
Factors Influencing the SSRI-Prescribing Practices of 




Direct to consumer advertising 1 3.0
Drug manufacture influence 4 13.0
Efficacy 22 73.0
Managed care formulary 19 63.0
Patient profile 23 77.0
Side effects 26 87.0
Other 0 0.0
Note. Percentages were rounded to the nearest 10̂ .̂ 
Participants were asked to "check all that apply," so 
percentages total more than 100%.
^N = 30.
Item 7 on the Dowell Prescribing Practice 
Questionnaire was designed to elicit whether or not 
primary care providers prescribe other types of treatment 
before prescribing an antidepressant. Sixty percent 
reported that they do prescribe other types of treatment 
before prescribing an antidepressant. Forty percent
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reported that they do not prescribe any other types of 
treatment.
Item 8 on the Dowell Prescribing Practice 
Questionnaire only applied to those participants who 
answered yes to item 7. Item 8 listed types of treatment 
for depression other than medication. The participants 
were asked to check all that apply. Professional 
counseling and exercise were recommended the most 
frequently. Responses to item 8 can be found in Table 7.
Table 7
Treatments Prescribed for the Treatment of Depression by 




Light therapy 2 7.0
Professional counseling 11 37.0
Self-help literature 2 7.0
Spiritual counseling 7 23.0
Suicide precautions 3 10.0
Support groups 4 13.0
Other 1 3.0
Note: Participants were asked to "check all that apply, 
so percentages total more than 100%. Percentages were 
rounded to the nearest 10̂ .̂
= 30.
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Research Question 2 read as follows: What is the 
perceived competency level of primary care providers in 
prescribing SSRIs? Items 10 and 11 on the Dowell 
Prescribing Practice Questionnaire were designed to elicit 
answers to this question. Item 10 asked respondents to 
rate themselves regarding how competent they felt 
prescribing SSRIs. The ranking scale ranged from 1 (not 
competent) to 4 (very competent).
Among the respondents, none answered not competent or 
slightly competent. Nine of the respondents (32%) answered
fairly competent, and 19 of the respondents (68%) answered
very competent. Two of the respondents had no response.
The same question format was also used to assess the 
competency level of the respondents regarding answering 
client questions related to SSRIs. None of the respondents 
answered not competent or slightly competent. Ten of the 
respondents (34%) answered fairly competent, and 19 of the 
respondents (66%) answered very competent. One respondent 
did not respond to this question.
To further elucidate findings related to the research 
questions, item 9 on the Dowell Prescribing Practice
Questionnaire stated the following : How was the
prescribing of SSRIs covered in your basic medical 
education? The results were as follows : Briefly (n = 11, 
44%), moderately (n = 6, 24%), and sufficiently (n = 8,
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32%). Four respondents wrote in "none" or "not at all" 
rather than selecting any of the three provided options. 
These four respondents indicated that they did not cover 
prescribing SSRIs in their basic medical education. The 
ages of these four participants were 59, 53, 49, and 46 
years.
These findings reveal that the majority of the primary 
care providers in this study perceive a high level of 
competence in prescribing SSRIs. The results also 
indicated that the respondents perceive a high level of 
competence in answering patients' questions about SSRIs.
Additional Findings
Respondents were also given the opportunity to
express additional comments concerning their prescribing
practices. There were four responses to this part of the
questionnaire. The following are comments collected from
the questionnaire :
A significant number of depressed patients that 
I see are bipolar and need mood stabilization 
before antidepressant treatment.
SSRIs are frequently prescribed and often very 
helpful. It is good that you are studying this. 
We had almost no training in depression, yet it 
is treated almost as often as colds and 
allergies in my experience.
52
Preferred medication for depression in my 
practice is Effexor XR.
Summary
Chapter IV presented data obtained from the 
Demographic Survey and the Dowell Prescribing Practices 
Questionnaire. Data were analyzed to answer research 
questions concerning the SSRI-prescribing practices of 
primary care providers in a southeastern state.
Statistical findings were presented. Chapter V contains an 
interpretation of the data described in this chapter, as 




The purpose of this study was to determine the SSRI- 
prescribing practices among primary care providers. SSRIs 
are frequently being prescribed in the primary care area. 
This researcher posed the following two research 
questions :
1. What are the factors that influence the 
prescribing practices of primary care 
providers regarding SSRIs?
2. What is the perceived competency level of primary 
care providers in prescribing SSRIs?
Benner's Novice to Expert nursing served as the 
theoretical framework for this study. The sample consisted 
of 30 primary care providers ranging in age from 29 to 7 0 
years who are currently practicing in a southeastern 
state. The respondents, 16 females and 14 males, were 
predominantly Caucasian who practice in a primary care 
setting. Data for the study were obtained using a 
researcher-designed Demographic Survey and the Dowell 
Prescribing Practices Questionnaire. Respondents were
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asked to complete the surveys and return them to the 
researcher by mail.
Summary of Findings
The sample {N = 30) used in this study consisted of 
primary care providers who were randomly chosen from a 
public physician and nurse practitioner directory. These 
providers were employed in primary care settings in a 
southeastern state.
The majority of the respondents reported seeing 
approximately 26 to 30 patients a day. Fifty-three percent 
of the respondents indicated that of the patients that 
they see, 25% suffer from depression. Diagnosing 
depression was most frequently based on the symptoms that 
the patient presented with and by the patient stating,
"I'm depressed." Of the patients treated for depression, 
the majority of the responders treat more than 75% of 
their patients with SSRIs. The most frequently prescribed 
SSRI reported was escitalopram, with the least often 
prescribed SSRI being fluovoxamine. Respondents reported 
that side effects of the drug most often influence which 
SSRI they choose. The majority of the providers do not 
recommend any other type of treatment before prescribing 
an antidepressant. Of the respondents who do, the most 
often suggested treatment was professional counseling.
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The majority of the respondents indicated that the 
prescribing of SSRIs was covered briefly in their basic 
medical education. There were 4 respondents who wrote in 
"none" or "not at all" due to SSRIs not existing while 
they were in medical school.
Sixty-eight percent of the respondents reported 
feeling very competent prescribing SSRIs. Thirty-two 
respondents indicated that they felt fairly competent 
prescribing SSRIs. There were only 28 responses to this 
question. Sixty-six percent of the respondents felt very 
competent answering patient questions about SSRIs. Thirty- 
four percent reported feeling fairly competent answering 
patients' questions.
Discussion
Findings for the first research question. What are 
the factors that influence the prescribing practices of 
primary care providers regarding SSRIs?, revealed that 93% 
of the respondents diagnose depression by the patient's 
presenting symptoms. Ferguson (2000) reported that because 
no laboratory tests exist for depression and no biological 
markers can be measured on a routine basis, the diagnosis 
of depression must be made using reliable depression 
scales and questionnaires that can be completed quickly in 
the primary care setting. Sixty-seven percent of the
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respondents in the current study also reported diagnosing 
a patient with depression if the patient states, "I'm 
depressed."
Shell (2001) found variation among the respondents 
prescribing practices of antidepressants and in some cases 
variation from established guidelines. The findings are 
significant because this study also found variation in the 
diagnosing and treatment of depression. The Shell (2001) 
study also reported 56% of the respondents felt that they 
needed to be further educated on antidepressants. Of the 
respondents in the current study, 44% reported being 
educated on the prescribing of SSRIs briefly in their 
basic medical education. A lack of education could 
contribute to poor patient education and outcome of 
treatment. Stafford et al. (2000) discovered that 7.8% of 
primary care visits were related to a diagnosis of 
depression. Antidepressants (42%) were found to be the 
most popular choice of treatment. SSRIs (25.8%) were found 
to be the most often prescribed antidepressant. The 
respondents of the current study also reported that SSRIs 
(38%) are used more than 75% of the time in treating 
depression.
The question, what factors influence which SSRI you 
choose?, also indicates one's prescribing practices. The 
findings of this question reflected that side effects
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(87%) were the most influential factor. Side effects were 
followed closely by the patient profile. Shell's (2001) 
study indicated efficacy (68%) and the nurse 
practitioners' knowledge of the antidepressant (42%) as 
determining factors of which antidepressant they choose. 
Cost factors (61%), potential for drug interaction (66%), 
and the patients' associated medical questions (66%) were 
reported as being the other highly influential factors.
The second question that guided this study, what is 
the perceived competency level of primary care providers 
in prescribing SSRIs?, found that all of the respondents 
felt either very competent (68%) or fairly competent (32%) 
prescribing SSRIs. The respondents also reported feeling 
very competent (66%) or fairly competent (34%) answering 
patient questions about SSRIs. These findings are 
significant due to the idea that a high competency level 
of the primary care provider could contribute to better 
patient education, therefore, better patient compliance.
In a similar study. Shell (2001) reported 71% of the 
respondents felt comfortable in choosing an antidepressant 




The findings of this study alerted the researcher 
that primary care providers are treating more patients 
diagnosed with depression than ever before. The majority 
of respondents reported that 25% of their patients suffer 
from depression. Of those patients, more than 75% are 
treated with an SSRI. Escitalopram was the most prescribed 
SSRI, followed by sertaline. Side effects of the drug were 
most influential in choosing an SSRI, followed closely by 
patient profile. The researcher was interested in the 
hastiness of the prescriber to prescribe a medication 
before prescribing another type of treatment.
Interestingly, a little more than half of the respondents 
recommend that their patient try another type of treatment 
before they prescribe the patient an antidepressant. The 
treatments most frequently recommended include 
professional counseling, exercise, and spiritual 
counseling.
The findings of this study also indicated that 
primary care providers perceive a very high level of 
competency or feel fairly competent in prescribing SSRIs. 
The perceived level of competency of the respondents was 
greater than expected by the researcher. The respondents 
reported similar competency levels in answering patients'
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questions about SSRIs. Four of the respondents who 
reported feeling fairly competent stated that SSRIs were 
not developed at the time they were in school. Therefore, 
they had no formal education on this class of 
antidepressants.
Implications for Nursing
This research sought to explore the SSRI-prescribing 
practices of primary care providers. Having knowledge 
about their prescribing practices can determine areas in 
need of further education. Findings from this study will 
provide information that will assist in the optimal 
diagnosing and treatment of depression. This study will 
reveal knowledge that will have implications for the 
primary care provider in the areas of education, practice, 
theory, and research.
Education. Findings from this study revealed that the 
majority of primary care providers treat depression with 
an SSRI. With this increasing popularity, information 
regarding the use of SSRIs is essential in schools of 
medicine and nursing. For personal knowledge, primary care 
providers need to participate in continuing education that 
would keep them updated on the latest information 
regarding SSRIs. Primary care providers must be able to
60
educate their patients on SSRIs. Continuing education is 
vital in giving patients holistic care.
Practice. In the primary care setting, primary care 
providers must be prepared to initiate and facilitate 
conversation regarding the benefits, contraindications, 
and side effects of SSRIs. As the primary care provider 
gains knowledge through continuing education, self-study, 
or conferences, protocols may be developed regarding the 
prescribing of SSRIs in the primary care setting. The 
current study reinforces the importance of primary care 
providers increasing their competence levels to ensure 
that their patients receive optimal care.
Theory. Benner's (2001) Novice to Expert Model was an 
appropriate framework for this study. The model consists 
of five levels that are necessary for a primary care 
provider to progress through to acquire competence. These 
levels include novice, advanced beginner, competent, 
proficient, and expert. Movement through these levels is 
accomplished by expanding one's knowledge base by 
participating in continuing education and through 
experience. This increase in knowledge and experience will 
aid in the primary care provider becoming a confident and 
competent health care provider. The ultimate goal of this 
process is to offer the patient the best care possible.
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Research. This study sought to explore the SSRI- 
prescribing practices of primary care providers. Findings 
from the study revealed that 38% of primary care providers 
treat more than 75% of their patients diagnosed with 
depression with an SSRI compared with the 7% who prescribe 
SSRIs less than 25% of the time. Publication of nursing 
research is needed regarding the SSRI-prescribing 
practices of primary care providers. The findings of the 
research will increase primary care providers' awareness 
of the prescribing practices of other primary care 
providers.
Limitations
The survey resulted in a small sample size; 
therefore, generalization of the findings beyond the 
sample may be impossible. The sampling design was one of 
convenience, thus the sample may not have adequately 
represented the characteristics of the population of 
primary care providers. Respondents may have interpreted 
the questions asked in the survey in different ways. The 
accuracy of the data collected may depend upon the 
respondents' willingness to share their personal beliefs 
and prescribing practices.
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The researcher-designed instruments used to gather 
data were assumed to have face validity. The initial use 
of these instruments occurred in this current study. The 
instruments were self-administered, and data were not 
validated.
Recommendations for Further Study-
Based on the findings of this study, recommendations 
for further study are made. The recommendations are as 
follows :
1. Replication of the study using a larger, more 
diverse sample of primary care providers, 
including primary care providers from other 
geographical areas.
2. Conducting research using participants who have 
been prescribed an SSRI by a primary care 
provider.
3. Education of primary care providers on prescribing 
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Please check (%/) and or fill in the appropriate responses
1. Age:_________
2. Gender
O  a . Female 
O  b . Male
3. Ethnicity
O  a. African American 
O  b. Caucasian 
O  c . Other. Please specify
4. Specify profession 
Ü  a. Medical doctor
O  b . Nurse practitioner
5. Length of time that you have practiced as medical doctor 
or nurse practitioner:_____________________________________
APPENDIX B
DOWELL PRESCRIBING PRACTICE QUESTIONNAIRE
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Dowell Prescribing Practice Questionnaire 
Please place a check {/) and or fill in the appropriate responses.
1. In your role as  an MD or NP, approximately how many patients do you see
per day?
□  a. < 10
□  b. 10 to 15
□  c. 16 to 20
□  d. 21 to 25
□  e. 26 to 30
□  f. > 30
2. Approximately what percent of the patients that you see  suffer from 
depression?
□  a. < 15%
□  b. 25%
□  c. 50%
□  d. 75%
□  e. >75%
3. What methods do you use to diagnose depression? (Check all that apply) 
O  a. DSM-IV criteria
d  b. Established quantitative screening tool for depression 
d  c. Patient states, “I am depressed.”
d  d. Patient presents with symptoms of depression.
d  e. Other(s). P lease list:_________________________________________
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4. Considering the patients that you treat for depression, approximately what 
percent do you treat with an SSRI?
□  a. < 15%
□  b. 25%
□  c. 50%
□  d. 75%
□  e. >75%
5. Rank the following SSRIs by circling the number that represents the order of 






































6. What factors influence which SSRI you choose? (Check all that apply) 
d  a. Cost
d  b. Direct to consumer advertising 
d  c. Drug manufacturer influence 
d  d. Efficacy
d  e. Managed care formulary 
d  f. Patient profile 
d  g. Side effects
d  h. Other. Please list:________________________________________
7. Do you routinely recommend that your patients try other types of treatment 
before you prescribe an antidepressant?
d  a. Yes 
□  b. No
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8. If you answered “yes” to #7, what other prescribed treatm ents or
recommendations regarding the treatment of depression are being m ade? 
(Check all that apply)
d  a. Exercise
d  b. Light therapy
d  c. Professional counseling
d  d. Self-help literature
d  e. Spiritual counseling
d  f. Suicide precautions
d  g. Support groups
d  h. Other. P lease specify:________________________________________
9. How w as the prescribing of SSRIs covered in your basic medical education? 
d  a. Briefly
d  b. Moderately 
d  c. Sufficiently
10. How competent do you feel prescribing SSRIs?
1 2  3 4
Not Slightly Fairly Very
competent competent competent competent
11. How competent do you feel about answering patient questions about 
SSRIs?
1 2  3 4
Not Slightly Fairly Very
competent competent competent competent
Additional Comments:
APPENDIX C
APPROVAL OF THE COMMITTEE ON USE 
OF HUMAN SUBJECTS IN EXPERIMENTATION 




U n iv e r s it yFOR̂ O M E N _____________________ ( Æ a
Admitting M en Since 1982 www.muw.edu
March 3, 2003
Ms. Ginger L. Dowell 
c/o Ms. Terri Hamill 
P. O. Box W-910 
Campus
Dear Ms. Dowell:
I am pleased to inform you that the members of the Committee on Human Subjects in 
Experimentation have approved your proposed research under the following conditions: (1) that 
names be taken off the envelopes; (2) that contact information be furnished so that anyone wanting 
the results can write for them and assume responsibility. The Committee was troubled by providing 
of lists of primary care providers at random from a pharmaceutical company prescribing lists. This 
list would be provided by a drug representative. The Committee felt this might be in violation of 
company policy, and they urge you to receive any consents and/or authorizations in writing from 
the pharmaceutical company prior to gleaning names from the list.
I wish you much success in your research.
Sincerely,
Vagn K. Hansen, Ph.D.
Provost and Vice President 
for Academic Affairs
VH.wr
cc: Mr. Jim Davidson
Ms. Terri Hamill 
Dr. Mary Pat Curtis
Where Excellence is a Tradition
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My name is Ginger Dowell. I am a registered nurse currently 
enrolled in the masters degree program at Mississippi 
University for Women. I am conducting a research study to 
determine the SSRI-prescribing practices of primary care 
providers. I would like for you to participate in my study. 
Your name was chosen from a drug company's prescribing list 
of health care providers in West Tennessee.
Participation is voluntary and your confidentiality will be 
maintained. You will be asked to fill out a survey regarding 
your prescribing practices of SSRIs. You will not be 
required to place your name on the survey. The completion 
and return of the survey in the self-addressed, stamped 
envelope will indicate your agreement to participate in the 
study. If you would like results of this study, place your 
name and address on the return envelope. Your survey will be 
separated from the envelope in order to maintain anonymity.
Thank you for your time and cooperation.
Sincerely,





Dear Primary Care Provider,
Thank you for participating in my research 
study. Primary Care Providers' Prescribing 
Practices of Selective Serotonin Reuptake 
Inhibitors. If you have not returned the 
Demographic Survey and the Dowell Prescribing 
Practice Questionnaire, please do so by June 1, 
2003,
Your assistance is appreciated.
Ginger L. Dowell
